CA2705142A1 - Diagnostics for aging-related dermatologic disorders - Google Patents

Diagnostics for aging-related dermatologic disorders Download PDF

Info

Publication number
CA2705142A1
CA2705142A1 CA 2705142 CA2705142A CA2705142A1 CA 2705142 A1 CA2705142 A1 CA 2705142A1 CA 2705142 CA2705142 CA 2705142 CA 2705142 A CA2705142 A CA 2705142A CA 2705142 A1 CA2705142 A1 CA 2705142A1
Authority
CA
Canada
Prior art keywords
allele
gene
allelic
aging
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2705142
Other languages
English (en)
French (fr)
Inventor
Kenneth S. Kornman
Leon Wilkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interleukin Genetics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2705142A1 publication Critical patent/CA2705142A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
CA 2705142 2007-11-08 2008-11-10 Diagnostics for aging-related dermatologic disorders Abandoned CA2705142A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98633107P 2007-11-08 2007-11-08
US60/986,331 2007-11-08
PCT/US2008/012633 WO2009061506A2 (en) 2007-11-08 2008-11-10 Diagnostics for aging-related dermatologic disorders

Publications (1)

Publication Number Publication Date
CA2705142A1 true CA2705142A1 (en) 2009-05-14

Family

ID=40514080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2705142 Abandoned CA2705142A1 (en) 2007-11-08 2008-11-10 Diagnostics for aging-related dermatologic disorders

Country Status (5)

Country Link
US (1) US20090170105A1 (enExample)
EP (1) EP2217725A2 (enExample)
JP (1) JP2011502510A (enExample)
CA (1) CA2705142A1 (enExample)
WO (1) WO2009061506A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192429B2 (en) 2010-06-29 2012-06-05 Theravant, Inc. Abnormality eradication through resonance
GB2513268B (en) * 2012-01-04 2020-04-15 South African Medical Res Council Oligonucleotides and methods for determining a predisposition to soft tissue injuries
JP6598450B2 (ja) * 2014-10-28 2019-10-30 花王株式会社 皮膚性状判定のための遺伝子検出方法
CA3011363A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CA3142662A1 (en) 2019-06-06 2020-12-10 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19
WO2025137572A1 (en) * 2023-12-20 2025-06-26 New York University Coq10 repletion using 4-hma

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US6951721B2 (en) * 1996-02-12 2005-10-04 Gene Logic Inc. Method for determining the haplotype of a human BRCA1 gene
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9621129D0 (en) * 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
GB9723553D0 (en) * 1997-11-07 1998-01-07 Duff Gordon W Prediction of the risk of chronic obstructive airway disease
US6746839B1 (en) * 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US6931326B1 (en) * 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
WO2002101631A1 (en) * 2001-06-08 2002-12-19 President And Fellows Of Harvard College Haplotype determination
EP1463745A4 (en) * 2001-11-19 2007-11-07 Interleukin Genetics Inc FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 SITE AFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TO INFLAMMATORY AND INFECTIOUS DISEASES
JP2005529608A (ja) * 2002-06-14 2005-10-06 シーダーズ−サイナイ・メディカル・センター インスリン耐性、冠動脈疾患およびその他の表現型の発生のリスクを判断するためのハプロタイプに基づく遺伝子分析方法

Also Published As

Publication number Publication date
EP2217725A2 (en) 2010-08-18
US20090170105A1 (en) 2009-07-02
WO2009061506A9 (en) 2009-09-11
JP2011502510A (ja) 2011-01-27
WO2009061506A3 (en) 2009-07-16
WO2009061506A2 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
US20020146700A1 (en) Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
US20030152947A1 (en) Methods for detecting and treating the early onset of aging-related conditions
US20090163460A1 (en) Diagnostics and therapeutics for early-onset menopause
US20090170105A1 (en) Diagnostics for Aging-Related Dermatologic Disorders
AU2006203097B2 (en) Diagnostics and therapeutics for osteoporosis
US8101360B2 (en) IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
US20080254478A1 (en) Il-gene cluster and associated inflammatory polymorphisms and haplotypes
WO2001016377A9 (en) Diagnostics and therapeutics for osteoporosis
AU2004263184B2 (en) Diagnostic and therapeutics for osteoporosis
US20090023147A1 (en) Diagnostics and therapeutics for osteoporosis
US8105775B2 (en) IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2565562A1 (en) Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
HK1093757B (en) Diagnostic for osteoporosis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20131108

FZDE Discontinued

Effective date: 20151110